News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Accium BioSciences, Inc. Takes $3 Million Series A
January 6, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Accium BioSciences, a provider of bioanalytical services with a focus on early-stage drug development, has raised $3 million in a Series A round.
Twitter
LinkedIn
Facebook
Email
Print
Startups
MORE ON THIS TOPIC
Funding
Novo Foundation Pumps $850M Into Denmark, Europe to Bolster Innovation
January 16, 2026
·
2 min read
·
Tristan Manalac
RNA editing
JPM26: Korro Bio Looks To Save Itself Despite Unenviable Position
January 16, 2026
·
3 min read
·
Dan Samorodnitsky
Drug pricing
Trump Takes Drug Pricing Fight To Insurers With ‘The Great Healthcare Plan’
January 15, 2026
·
2 min read
·
Annalee Armstrong
Legal
Compounder Sues Lilly, Novo, Claims Coordinated Crackdown
January 15, 2026
·
2 min read
·
Tristan Manalac
